According to our latest research, the global Specific Antiviral Drugs for COVID-19 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

Global Specific Antiviral Drugs for COVID-19 Scope and Market Size

This report focuses on the global Specific Antiviral Drugs for COVID-19 status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Specific Antiviral Drugs for COVID-19 development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.


Segment by Type


Tablet

Injection


Segment by Application


Mild Symptom Patient

Critically Ill Patient

By Region

North America

Europe

China

Japan

Southeast Asia

India

Central & South America


By Company


Sanofi

Novartis

Shanghai Zhongxisanwei

Teva

Zydus Cadila

Mylan

Apotex

Advanz Pharma

Sun Pharma

Kyung Poong

Ipca Laboratories

Hanlim Pharmaceutical

Bristol Laboratories

Bayer

Rising Pharmaceutical

Shanghai Pharma

Sichuan Sunny Hope

Guangzhou Baiyunshan Guanghua Pharmaceutical

CSPC Group

KPC Group

Jinghua Pharmaceutical Group

Zhongsheng Pharma

North China Pharmaceutical Group